JAMES C YAO to Colonic Neoplasms
This is a "connection" page, showing publications JAMES C YAO has written about Colonic Neoplasms.
Connection Strength
0.206
-
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet. 2023 07 01; 402(10395):41-53.
Score: 0.123
-
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated colon and rectum tumour/carcinoma. Neuroendocrinology. 2008; 87(1):31-9.
Score: 0.084